An IL‐6‐STAT3 loop was shown to mediate resistance to PI3K inhibitors by inducing epithelial–mesenchymal transition (EMT) and cancer stem cell expansion in human breast cancer cells (Yang et al., 2014). The gene discussed is IL6; the disease is breast cancer.